OTC Markets OTCQX - Delayed Quote USD

Integrated BioPharma, Inc. (INBP)

0.3400
-0.0100
(-2.86%)
At close: May 16 at 4:00:00 PM EDT
Loading Chart for INBP
  • Previous Close 0.3500
  • Open 0.3400
  • Bid 0.3300 x --
  • Ask 0.3500 x --
  • Day's Range 0.3400 - 0.3500
  • 52 Week Range 0.1600 - 0.4200
  • Volume 12,407
  • Avg. Volume 14,409
  • Market Cap (intraday) 10.302M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 11.33
  • EPS (TTM) 0.0300
  • Earnings Date May 14, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. It operates through two segments, Contract Manufacturing and Other Nutraceutical Businesses. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment distributes healthful nutritional products for sale through mass market, grocery, drug, and vitamin retailers under the Peaceful Sleep and Wheatgrass brand names, as well as other branded proprietary nutraceutical products. This segment also sells private label vitamin and nutritional supplement products through the Internet; provides warehousing and fulfilment services; and distributes fine natural botanicals, including multi minerals, as well as raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.

ir.ibiopharma.com

147

Full Time Employees

June 30

Fiscal Year Ends

Recent News: INBP

View More

Performance Overview: INBP

Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

INBP
3.03%
S&P 500 (^GSPC)
1.30%

1-Year Return

INBP
54.55%
S&P 500 (^GSPC)
12.48%

3-Year Return

INBP
56.96%
S&P 500 (^GSPC)
48.66%

5-Year Return

INBP
32.00%
S&P 500 (^GSPC)
108.07%

Compare To: INBP

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INBP

View More

Valuation Measures

Annual
As of 5/16/2025
  • Market Cap

    10.30M

  • Enterprise Value

    9.16M

  • Trailing P/E

    10.11

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.20

  • Price/Book (mrq)

    0.52

  • Enterprise Value/Revenue

    0.18

  • Enterprise Value/EBITDA

    3.38

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    0.0300

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: INBP

View More

Company Insights: INBP

Research Reports: INBP

View More

People Also Watch